| Website | tgbfund.com.tw |
| Phone | 886-2-2396-1166 |
| biofund@yfy.com | |
| Employees | |
| Founded | 2003 |
| Description | biotechnology investment companies |
Established in Nov 2003, YFY biotech Management Company is one of the leading biotechnology investment companies in Taiwan. We focus exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, medical devices, medical services, medical informatics and related medical technologies with a potential to become an industrial leader. We currently manage Taiwan Global Biofund (TGB), with a fund size of approximately US$70 million. The financial, regulatory and scientific expertise of the firm’s investment team, strategic partners and Steering Committee not only competent in making investment decisions, also helps to build the value of portfolio companies and to accelerate their growth and development.
| Company | Date | Round | Size | Participants |
| TaiMed Biologics | 3/10 | Series B | $22M | 2 |
| Elixir Pharmaceuticals | 11/06 | Series C | $46M | 6 |
